<DOC>
	<DOC>NCT01336244</DOC>
	<brief_summary>The purpose of the study is to evaluate the safety and tolerability of multiple ascending oral doses (MAD) of GLPG0778 given to healthy subjects for 13 days compared to placebo, and to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of GLPG0778 after multiple oral administrations.</brief_summary>
	<brief_title>GLPG0778: Multiple Ascending Oral Doses, Pharmacokinetic, Safety, and Pharmacodynamic Study</brief_title>
	<detailed_description />
	<criteria>healthy male, age 1850 years body mass index (BMI) between 1830 kg/mÂ², inclusive. significantly abnormal platelet function or coagulopathy smoking drug or alcohol abuse hypersensitivity to any of the test substances</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>